Christine is a freelance writer for Collider with two decades of experience covering all types of TV shows and movies spanning every genre. With a particular affinity for dramas, true crime, sitcoms, ...

“I think that I should contribute money to Jasmine Crockett and then let everybody know that she also took money from Jeffrey Epstein,” Epstein told The Post. Crockett boasted on the House floor this ...

India's Tejas crashed at the Dubai Air Show. Officials to soon share details. Times Now brings you the exam moment of Tejas Crash. Watch the video to know more. Explained: Why billionaire Lakshmi ...

Abbott’s roughly $21 billion acquisition of cancer screening firm Exact Sciences lays out the company’s future strategy. Analysts said the acquisition not only marks Abbott’s foray into cancer ...

Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics ...

Good morning, and thank you for standing by. Welcome to Abbott's conference call. [Operator Instructions]. This call is being recorded by Abbott. With the exception of any participants' questions ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Abbott Laboratories ABT-1.10%decrease; red down pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.04%increase; green up pointing triangle in a deal valued at about ...

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Exact Sciences, one of Madison’s largest biotech companies, has agreed to be acquired by Abbott Laboratories for $23 billion, the Illinois-based company announced Thursday.